drugset / Trial / NCT00988520

Study of Efficacy, Pharmacokinetics and Safety of Continuous Intravenous Infusion of Org 9426 (Study P05977)

NCT00988520

Phase 3 Completed 38 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare the infusion rate of Org 9426 following intubating dose of Org 9426 0.6 mg/kg or 0.9 mg/kg in adult surgical patients.

Timeline

Start
2003-05
Primary completion
2003-09
Completion
2003-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Rocuronium Other / unclassified 7 ug/kg Intravenous
Background Propofol Small molecule 4010 mg/kg Intravenous
Background Sevoflurane Other / unclassified 0.5 % Intravenous
Background Sevoflurane Other / unclassified 2 % Intravenous

Indications

No indication recorded.